WuXi had a banner 2012; Synteract buys German CRO;

> WuXi PharmaTech ($WX) says it has hit the $500 million revenue mark for 2012. News

> CDMO Almac has partnered with TTP Labtech to create a robust, antibody-free, homogeneous assay platform for their clients. More

> Synteract has signed a deal to buy German CRO Harrison Clinical Research for an undisclosed amount of money. Article

> Mitsubishi Chemical Holdings is buying Qualicaps for $650 million, planning to fold the business into its API manufacturing and other healthcare operations. Story

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

WCG is continuing its buyout run after acquiring clinical trial solutions firm Trifecta Clinical.

London-based uMed has raised nearly $4.8 million from U.K. and U.S. VCs to help healthcare providers participate in more clinical studies.

Amgen has teamed up with cloud-based trial solutions firm Reify Health to help boost patients into its drug studies.